Published in Antiviral Res on May 23, 2006
Tegument proteins of human cytomegalovirus. Microbiol Mol Biol Rev (2008) 1.50
Cytomegalovirus in hematopoietic stem cell transplant recipients. Hematol Oncol Clin North Am (2011) 1.42
In vitro and in vivo activities of the novel anticytomegalovirus compound AIC246. Antimicrob Agents Chemother (2010) 1.36
Function of human cytomegalovirus UL97 kinase in viral infection and its inhibition by maribavir. Rev Med Virol (2009) 1.31
Stereoselective phosphorylation of cyclopropavir by pUL97 and competitive inhibition by maribavir. Antimicrob Agents Chemother (2010) 1.15
The genetic basis of human cytomegalovirus resistance and current trends in antiviral resistance analysis. Infect Disord Drug Targets (2011) 1.10
Optimal management of cytomegalovirus retinitis in patients with AIDS. Clin Ophthalmol (2010) 1.08
Artemisinin-derived dimers have greatly improved anti-cytomegalovirus activity compared to artemisinin monomers. PLoS One (2010) 1.04
Human cytomegalovirus UL50 and UL53 recruit viral protein kinase UL97, not protein kinase C, for disruption of nuclear lamina and nuclear egress in infected cells. J Virol (2013) 1.03
Regulation of the retinoblastoma proteins by the human herpesviruses. Cell Div (2009) 1.02
Cytomegalovirus reactivation in critically ill immunocompetent hosts: a decade of progress and remaining challenges. Antiviral Res (2011) 1.00
Cyclopropavir inhibits the normal function of the human cytomegalovirus UL97 kinase. Antimicrob Agents Chemother (2011) 0.98
Progress in the development of new therapies for herpesvirus infections. Curr Opin Virol (2011) 0.95
Prevention of maternal cytomegalovirus infection: current status and future prospects. Int J Womens Health (2010) 0.95
The search for new therapies for human cytomegalovirus infections. Virus Res (2010) 0.95
Current and emerging antivirals for the treatment of cytomegalovirus (CMV) retinitis: an update on recent patents. Recent Pat Antiinfect Drug Discov (2012) 0.94
Human cytomegalovirus tegument proteins (pp65, pp71, pp150, pp28). Virol J (2012) 0.94
Impaired functionality of antiviral T cells in G-CSF mobilized stem cell donors: implications for the selection of CTL donor. PLoS One (2013) 0.94
Inhibition of cyclooxygenase activity blocks cell-to-cell spread of human cytomegalovirus. Proc Natl Acad Sci U S A (2008) 0.94
Conserved retinoblastoma protein-binding motif in human cytomegalovirus UL97 kinase minimally impacts viral replication but affects susceptibility to maribavir. Virol J (2009) 0.94
Human cytomegalovirus UL97 kinase and nonkinase functions mediate viral cytoplasmic secondary envelopment. J Virol (2011) 0.92
Synthesis and antiviral activities of methylenecyclopropane analogs with 6-alkoxy and 6-alkylthio substitutions that exhibit broad-spectrum antiviral activity against human herpesviruses. Antimicrob Agents Chemother (2013) 0.92
Amphipathic DNA polymers exhibit antiviral activity against systemic murine Cytomegalovirus infection. Virol J (2009) 0.91
Fluorescence-based assay for phenotypic characterization of human cytomegalovirus polymerase mutations regarding drug susceptibility and viral replicative fitness. Antimicrob Agents Chemother (2009) 0.91
Myeloblastic cell lines mimic some but not all aspects of human cytomegalovirus experimental latency defined in primary CD34+ cell populations. J Virol (2013) 0.89
Expansion of cytomegalovirus pp65 and IE-1 specific cytotoxic T lymphocytes for cytomegalovirus-specific immunotherapy following allogeneic stem cell transplantation. Biol Blood Marrow Transplant (2008) 0.89
Resistance of human cytomegalovirus to cyclopropavir maps to a base pair deletion in the open reading frame of UL97. Antimicrob Agents Chemother (2013) 0.88
The Varicella-zoster virus DNA encapsidation genes: Identification and characterization of the putative terminase subunits. Virus Res (2007) 0.87
Inhibition of herpesvirus replication by hexadecyloxypropyl esters of purine- and pyrimidine-based phosphonomethoxyethyl nucleoside phosphonates. Antimicrob Agents Chemother (2008) 0.86
Human cytomegalovirus UL97 kinase is involved in the mechanism of action of methylenecyclopropane analogs with 6-ether and -thioether substitutions. Antimicrob Agents Chemother (2013) 0.85
Ganciclovir-resistant cytomegalovirus infections among lung transplant recipients are associated with poor outcomes despite treatment with foscarnet-containing regimens. Antimicrob Agents Chemother (2013) 0.85
Establishment of a cell-based assay for screening of compounds inhibiting very early events in the cytomegalovirus replication cycle and characterization of a compound identified using the assay. Antimicrob Agents Chemother (2008) 0.84
Murine cytomegalovirus protein pM92 is a conserved regulator of viral late gene expression. J Virol (2013) 0.84
Sites and roles of phosphorylation of the human cytomegalovirus DNA polymerase subunit UL44. Virology (2011) 0.84
An epistatic relationship between the viral protein kinase UL97 and the UL133-UL138 latency locus during the human cytomegalovirus lytic cycle. J Virol (2014) 0.84
An artesunate-containing antimalarial treatment regimen did not suppress cytomegalovirus viremia. J Clin Virol (2013) 0.83
Cytomegalovirus pneumonia in hematopoietic stem cell recipients. J Intensive Care Med (2013) 0.83
A model of human cytomegalovirus infection in severe combined immunodeficient mice. Antiviral Res (2007) 0.83
Susceptibilities of human cytomegalovirus clinical isolates and other herpesviruses to new acetylated, tetrahalogenated benzimidazole D-ribonucleosides. Antimicrob Agents Chemother (2009) 0.83
The ULb' region of the human cytomegalovirus genome confers an increased requirement for the viral protein kinase UL97. J Virol (2013) 0.82
Effect of ganciclovir for the treatment of severe cytomegalovirus-associated pneumonia in children without a specific immunocompromised state. BMC Infect Dis (2013) 0.82
DSTP-27 prevents entry of human cytomegalovirus. Antimicrob Agents Chemother (2014) 0.82
Cytomegalovirus antivirals and development of improved animal models. Expert Opin Drug Metab Toxicol (2011) 0.81
Human cytomegalovirus UL97 kinase alters the accumulation of CDK1. J Gen Virol (2012) 0.81
VCL-CB01, an injectable bivalent plasmid DNA vaccine for potential protection against CMV disease and infection. Curr Opin Mol Ther (2009) 0.81
Engineering of a chimeric RB69 DNA polymerase sensitive to drugs targeting the cytomegalovirus enzyme. J Biol Chem (2009) 0.81
Expression of the human cytomegalovirus UL97 gene in a chimeric guinea pig cytomegalovirus (GPCMV) results in viable virus with increased susceptibility to ganciclovir and maribavir. Antiviral Res (2008) 0.81
Characterization of the Varicella-zoster virus ORF25 gene product: pORF25 interacts with multiple DNA encapsidation proteins. Virus Res (2009) 0.81
Adoptive immunotherapy with CMV-specific cytotoxic T lymphocytes for stem cell transplant patients with refractory CMV infections. J Immunother (2012) 0.80
Current and Potential Treatments for Ubiquitous but Neglected Herpesvirus Infections. Chem Rev (2014) 0.80
Oral hexadecyloxypropyl-cidofovir therapy in pregnant guinea pigs improves outcome in the congenital model of cytomegalovirus infection. Antimicrob Agents Chemother (2010) 0.80
Maribavir inhibits Epstein-Barr virus transcription through the EBV protein kinase. J Virol (2013) 0.80
The oncomodulatory role of human cytomegalovirus in colorectal cancer: implications for clinical trials. Front Oncol (2014) 0.80
Rationally designed chemokine-based toxin targeting the viral G protein-coupled receptor US28 potently inhibits cytomegalovirus infection in vivo. Proc Natl Acad Sci U S A (2015) 0.79
Metabolism of cyclopropavir and ganciclovir in human cytomegalovirus-infected cells. Antimicrob Agents Chemother (2014) 0.78
Guinea pig cytomegalovirus GP84 is a functional homolog of the human cytomegalovirus (HCMV) UL84 gene that can complement for the loss of UL84 in a chimeric HCMV. Virology (2010) 0.78
Analysis of essential viral gene functions after highly efficient adenofection of cells with cloned human cytomegalovirus genomes. Viruses (2014) 0.78
Immune response to HHV-6 and implications for immunotherapy. Curr Opin Virol (2014) 0.78
The Varicella-zoster virus ORF54 gene product encodes the capsid portal protein, pORF54. Virus Res (2012) 0.78
Does Cytomegalovirus Develop Resistance following Antiviral Prophylaxis and Treatment in Renal Transplant Patients in Kuwait? Adv Virol (2011) 0.77
Phase 1 Randomized, Double-Blind, Placebo-Controlled Study of RG7667, an Anticytomegalovirus Combination Monoclonal Antibody Therapy, in Healthy Adults. Antimicrob Agents Chemother (2015) 0.77
KSHV targeted therapy: an update on inhibitors of viral lytic replication. Viruses (2014) 0.77
Preemptive therapy prevents cytomegalovirus end-organ disease in treatment-naïve patients with advanced HIV-1 infection in the HAART era. PLoS One (2013) 0.77
A Hsp40 chaperone protein interacts with and modulates the cellular distribution of the primase protein of human cytomegalovirus. PLoS Pathog (2012) 0.77
Human cytomegalovirus primase UL70 specifically interacts with cellular factor Snapin. J Virol (2011) 0.77
In vitro drug combination studies of Letermovir (AIC246, MK-8228) with approved anti-human cytomegalovirus (HCMV) and anti-HIV compounds in inhibition of HCMV and HIV replication. Antimicrob Agents Chemother (2015) 0.77
Disruption of Bcl-2 and Bcl-xL by viral proteins as a possible cause of cancer. Infect Agent Cancer (2014) 0.77
[Acute retinal necrosis from the virologist's perspective]. Ophthalmologe (2009) 0.77
Acute Herpetic Keratitis: What is the Role for Ganciclovir Ophthalmic Gel? Ophthalmol Eye Dis (2012) 0.77
Hemorrhagic cytomegalovirus colitis in a postoperative colon cancer patient. Case Rep Oncol (2013) 0.76
Prophylactic and therapeutic adenoviral vector-based multivirus-specific T-cell immunotherapy for transplant patients. Mol Ther Methods Clin Dev (2016) 0.76
CMV-Specific CD8 T Cell Differentiation and Localization: Implications for Adoptive Therapies. Front Immunol (2016) 0.76
Novel heparan sulfate-binding peptides for blocking herpesvirus entry. PLoS One (2015) 0.76
Inhibition of cellular STAT3 synergizes with the cytomegalovirus kinase inhibitor maribavir to disrupt infection. Antiviral Res (2013) 0.76
Non-axial view of the varicella-zoster virus portal protein reveals conserved crown, wing and clip architecture. Intervirology (2014) 0.76
Antiviral activity of cidofovir against telomerase-specific replication-selective oncolytic adenovirus, OBP-301 (Telomelysin). Invest New Drugs (2008) 0.76
Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection. PLoS Pathog (2017) 0.75
Inhibition of cyclophilin A suppresses H2O2-enhanced replication of HCMV through the p38 MAPK signaling pathway. FEBS Open Bio (2016) 0.75
SOCS1 and SOCS3 are expressed in mononuclear cells in human cytomegalovirus viremia after allogeneic hematopoietic stem cell transplantation. Blood Res (2015) 0.75
Recovery from a possible cytomegalovirus meningoencephalitis-induced apparent brain stem death in an immunocompetent man: a case report. J Med Case Rep (2016) 0.75
Pharmacokinetics of ganciclovir during continuous venovenous hemodiafiltration in critically ill patients. Antimicrob Agents Chemother (2013) 0.75
Human cytomegalovirus and transplantation: drug development and regulatory issues. J Virus Erad (2016) 0.75
Antiviral Drug Ganciclovir Is a Potent Inhibitor of the Proliferation of Müller Glia-Derived Progenitors During Zebrafish Retinal Regeneration. Invest Ophthalmol Vis Sci (2016) 0.75
Human cytomegalovirus resistance to deoxyribosylindole nucleosides maps to a transversion mutation in the terminase subunit-encoding gene UL89. Antimicrob Agents Chemother (2014) 0.75
Anti-cytomegalovirus activity of the anthraquinone atanyl blue PRL. Antiviral Res (2014) 0.75
Immunologic special forces: anti-pathogen cytotoxic T-lymphocyte immunotherapy following hematopoietic stem cell transplantation. Immunotargets Ther (2014) 0.75
A First-in-Human Study To Assess the Safety and Pharmacokinetics of Monoclonal Antibodies against Human Cytomegalovirus in Healthy Volunteers. Antimicrob Agents Chemother (2016) 0.75
Massive Alimentary Tract Bleeding due to Cytomegalovirus Infection in an Elderly Patient. Infect Dis Rep (2014) 0.75
Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients. Antimicrob Agents Chemother (2016) 0.75
The D-form of a novel heparan binding peptide decreases cytomegalovirus infection in vivo and in vitro. Antiviral Res (2016) 0.75
Modulation of the cellular distribution of human cytomegalovirus helicase by cellular factor Snapin. J Virol (2013) 0.75
Crystal structures of pure 3-(4-bromo-2-chloro-phen-yl)-1-(pyridin-4-yl)benzo[4,5]imidazo[1,2-d][1,2,4]triazin-4(3H)-one and contaminated with 3-(4-bromo-phen-yl)-1-(pyridin-4-yl)benzo[4,5]imidazo[1,2-d][1,2,4]triazin-4(3H)-one. Acta Crystallogr E Crystallogr Commun (2017) 0.75